Dispatch Bio Named a 2025 Startup Company to Watch by Endpoints News
The company was recognized for bringing ‘universality’ to cell therapies for solid tumors.
BlueWhale Bio Reaches Major Cell Therapy Clinical Milestone
The company aims to streamline the manufacturing process for huCART19-IL18 cells in the treatment of hematologic cancers.
FDA Approval of New Treatment for Glioma Based on Penn IP
This newly approved therapy is based on technology jointly owned by Penn, Wayne State University and Penn State University.
Smart Dosimetry System (SDS) Accepted into National NSF I-Corps Program
The program awards $50,000 to advance groundbreaking technologies through intensive customer discovery and market validation.
Penn Engineering Researchers Develop Novel Platform to More Efficiently Produce mRNA Delivery Particles
This new method not only allows for rapid production but also enables precise targeting the LNPs to specific organs like the liver, lungs and spleen.
Penn Medicine Researchers Use AI to Uncover Potential Antibiotic Compounds
The researchers used AI to analyze the genomes of tens of thousands of bacteria and other primitive organisms.
Penn Engineers Unlock the Potential for a New Generation of Wireless Communications
Researchers , have developed an adjustable high frequency filter that prevents signal interference in wireless communications and data transfers.
New Mini-documentary Showcases the Path to CAR-T Cell Therapy
This short documentary tells the powerful story of Bruce Levine, PhD, the Barbara and Edward Netter Professor in Cancer Gene Therapy at Penn Medicine, and the successful use of CAR-T cell therapy.
Penn Engineering Faculty Attend AI & Energy Summit in Pittsburgh
Penn Engineering faculty showcased Penn research, technologies, and start-up companies in the fields of energy, AI and computing.
Penn Medicine Highlights Public Funding’s Role in Translating Scientific Discoveries into Life-Saving Treatments
Stephen Bagley, MD, MSCE, Assistant Professor of Hematology-Oncology and Neurosurgery at Penn Medicine, discusses how he used CAR T cell therapy to shrink a patient's tumor.